Interleukins and Colony Stimulating Factors in Human Myeloid Leukemia Cell Lines

References

• Ihle J. N. Interleukin-3 and hematopoiesis. Chem. Immunol. 1992; 51: 65–106
   PubMed Web of Science ®Google Scholar
• Brach M. A., Hermann F. Interleukin-6: present and future. Int. J. Clin. Lab. Res. 1992; 22: 143–151
   PubMedGoogle Scholar
• Yang Y. C. Human Interleukin-9: a new cytokine in hematopoiesis. Leuk. Lymphoma 1992; 8: 441–447
   PubMed Web of Science ®Google Scholar
• Yang Y. C. Interleukin-11: an overview. Stem Cells 1993; 11: 474–486
   PubMed Web of Science ®Google Scholar
• Furmanski P., Johnson C. S. Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumour necrosis factor. Blood 1990; 75: 2328–2334
   PubMed Web of Science ®Google Scholar
• Bagby G. C. Interleukin-1 and hematopoiesis. Blood Rev. 1989; 3: 152–161
   PubMed Web of Science ®Google Scholar
• Hassan H. T., Grell S., Borrmann-Danso U., Freund M. Interleukin-4 inhibits the proliferation of MHH225 human leukemia megakaryoblastic cell line. Hematol. Oncol. 1994; 12: 61–66
   PubMed Web of Science ®Google Scholar
• Akashi K. The role of interleukin-4 in the negative regulation of leukemia cell growth. Leuk. Lymphoma 1993; 9: 205–209
   PubMed Web of Science ®Google Scholar
• Whetton A. D., Dexter T. M. Myeloid haemopoietic growth factors. Biochim. Biophysica. Acta 1989; 989: 11–132
   PubMed Web of Science ®Google Scholar
• Benjamin D., Park C. D., Sharma V. Human B-cell interleukin-10. Leuk. Lymphoma 1994; 12: 205–210
   PubMed Web of Science ®Google Scholar
• Tobler A., Moser B., Dewald B., Geiser T., Studer H., Baggiolini M., Fey M. F. Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia. Blood 1993; 82: 2517–2525
   PubMed Web of Science ®Google Scholar
• Koike M, Takatsu K. Interleukin-5 and its receptor: which role do they play in the immune response?. Int. Arch. Allergy Immunol. 1994; 104: 1–9
   PubMed Web of Science ®Google Scholar
• Kunisada T., Ogawa M., Hayashi S. I., Era T., Nishikawa S. I. Interleukin-7 and B-lymphopoiesis. Chem. Immunol. 1992; 51: 205–235
   PubMed Web of Science ®Google Scholar
• Clerigue M., Pisa P., Tsai L., Hanson M. Effects of interleukin-2 and interleukin-2-activated cells on in vitro myelopoiesis. Clin. Exp. Immunol. 1990; 81: 459–465
   PubMed Web of Science ®Google Scholar
• Hassan H. T., Rees J. K. H. Myeloid leukemogenesis and its reversal by combined differentiation induction therapy: A complementary model. Med. Sci. Res. 1990; 18: 47–52
   Google Scholar
• Naegeli O. Blutkrankheiten und Blutdiagnostik. Springer Verlag, Berlin 1931
   Google Scholar
• Srikanth S., Sokol L., Canfield M., Rado T. A. A human myeloid leukemia cell line (CC-AML) with stem cell characteristics. Blood 1993; 82: 23a
   Web of Science ®Google Scholar
• Keating A., Martin P. J., Bernstein I. D., Papayannopoulou T., Raskind W., Singer J. W. EM-2 and EM-3: two new Ph positive myeloid cell lines, D. W. Golde, P. Marks. Normal and Neoplastic Hematopoiesis, New York 1983; 513–520
   Google Scholar
• Ben-Bassat H., Korkesh A., Voss R., Leizerowitz R., Polliack A. Establishment and characterization of a new permanent cell line (GDM-1) from a patient with myelomonocytic leukemia. Leuk. Res. 1982; 6: 743–752
   PubMed Web of Science ®Google Scholar
• Rambaldi A., Bettoni S., Tosi S., Giudici G., Schiro R., Borleri G. M., Abbate M., Chiaffarino F., Colotta F., Barbui T. Establishment and characterization of a new granulocyte-macrophage colony stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8). Blood 1993; 81: 1376–1383
   PubMed Web of Science ®Google Scholar
• Oez S., Tittelbach H., Fahsold R., Avenarius H.-J. Establishment and characterization of a granulocyte-macrophage colony stimulating factor-dependent human myeloid leukemia cell line. Blood 1990; 76: 578–582
   PubMed Web of Science ®Google Scholar
• Abo J., Inokuchi K., Dan K., Nomura T. p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia. Blood 1993; 82: 2829–2836
   PubMed Web of Science ®Google Scholar
• Asou H., Tashiro S., Hamamoto K., Otsuji A., Kita K., Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031–2036
   PubMed Web of Science ®Google Scholar
• Andersson B. S., Beran M., Pathak S., Goodacre A., Barlogie B., McCredie K. B. Ph-positive chronic myeloid leukemia with near haploid conversion in vivo and establishment of a continuously growing cell line with similar cytogenetic pattern. Cancer Genet. Cytogenet. 1987; 124: 335–343
   Web of Science ®Google Scholar
• Kubonishi I., Miyoshi I. Establishment of Ph chromosome positive cell line from chronic myelogenous leukemia in blast crisis. Int. J. Cell Cloning 1983; 1: 105–117
   PubMedGoogle Scholar
• Koeffler H. P., Golde D. W. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 1978; 200: 1153–1154
   PubMed Web of Science ®Google Scholar
• Koeffler H. P., Billings R., Lusis A. J., Sparkes R., Golde D. W. An undifferentiated variant derived from the human acute myelogenous leukemia cell line KG-1. Blood 1980; 56: 265–273
   PubMed Web of Science ®Google Scholar
• Mori T., Nakazawa S., Nishino K., Sugita K., Takane K., Mori M., Sagawa K., Hayashi Y., Sakurai M. Ph-positive chronic myeloid leukemia derived myeloid-monocytic precursor cell line producing substances that stimulates normal CFU-C. Leuk. Res. 1987; 11: 241–249
   PubMed Web of Science ®Google Scholar
• Saito H., Kishi K., Narita M., Furukawa T., Nagura E., Maekawa T., Abe T., Chibata A. A new myeloblastic leukemia cell line KY821 with double minute chromosomes. Action of methotrexate resistance and dihydrofolate reductase gene. Leuk. Res. 1992; 16: 217–226
   PubMed Web of Science ®Google Scholar
• Ohkubo T., Kamamoto T., Kita K., Hiraoko A., Yoshida Y., Uchino H. A novel Ph-chromosome positive cell line KYO-1 established from a patient with chronic myelogenous leukemia in blastic crisis. Leuk. Res. 1985; 9: 921–926
   PubMed Web of Science ®Google Scholar
• Treves A. J., Halperin M., Barak V., Bar Tana R., Halimi M., Fibach E., Tamiel H., Leizerowitz R., Polliack A. A new myelomonoblastic cell line M20: analysis of properties, differentiation and comparison with other established lines of similar origin. Exp. Hematol. 1985; 13: 281–288
   PubMed Web of Science ®Google Scholar
• Tohyama K., Tsutani H., Ueda T., Nakamura T., Yoshida Y. Establishment and characterisation of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome. Br. J. Haematol. 1994; 87: 235–242
   PubMed Web of Science ®Google Scholar
• Okamura J., Yamada S., Ishii E., Hara T., Takahira H., Nishimura J., Yumura K., Kawa-Ha K., Takase K., Enomoto Y., Tasaka H. A novel leukemia cell line MR-87, with positive Philadelphia chromosome and negative breakpoint cluster reginn rearrangement coexpressing myeloid and early B-cell markers. Blood 1988; 72: 1261–1268
   PubMed Web of Science ®Google Scholar
• Ogura M., Morishima Y., Ohno R., Saito H., Kato K. Establishment and characterization of a new human myeloid cell line with Ph chromosome positive and myeloperoxidase from CML in myeloid blastic crisis. Jpn. J. Cancer Res. 1985; 76, Suppl., 597a
   Google Scholar
• Kataoka T., Morishita Y., Ogura M., Morishima Y., Towatari M., Kato Y., Inoue H., Saito H. A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony stimulating factor receptors and macrophage colony stimulating factor receptors. Cancer Res. 1990; 50: 7703–7709
   PubMed Web of Science ®Google Scholar
• Wang C., Koistinen P., Yang G. S., Williams D. E., Lyman S. D., Minden M. D., McCulloch E. A. Mast cell growth factor a ligand for the receptor encloded by c-kit, affects the growth in culture of the blast cells of acute myeloblastie leukemia. Leukemia 1991; 5: 493–499
   PubMed Web of Science ®Google Scholar
• Lucas D. L., Knight R. D., Khan E. C., Wright D. G. Isolation of a new human myeloid leukemia cell line RDFD-2 and the preparation of clonal derivative lines with differing capacities to undergo induced maturation. Blood 1983; 62: 152a
   PubMed Web of Science ®Google Scholar
• Mallet M. K., Mane S. M., Meltzer S. J., Needleman S. W. c-mye amplification coexistant with activating N-ras point mutation in the biphenotypic leukemia cell line RED-3. Leukemia 1989; 3, 511–515
   PubMed Web of Science ®Google Scholar
• Klingemann H. G., Gong H. J., Maki G., Horsman D. E., Dalal B. I., Phillips G. L. Establishment and characterization of a human leukemic cell line SR-91 with features suggestive of early hemopoietic progenitor cell origin. Leuk. Lymphoma 1994; 12: 463–470
   PubMed Web of Science ®Google Scholar
• Toaka T., Tasaka T., Tanaka T., Irino S., Norman A. W. Characterization, growth and differentiation of a human myeloid leukemia cell line, TI-1 cell. Blood 1992; 80: 46–52
   PubMed Web of Science ®Google Scholar
• Oval J., Jones O. W., Montoya M., Taetle R. Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26). Blood 1990; 76: 1369–1374
   PubMed Web of Science ®Google Scholar
• Yasukawa M., Yanagisawa K., Kohno H., Yakushijin Y., Kondo T., Fuija S. Simultaneous establishment of myeloid and B-lymphoid cell lines with identical chromosome abnormalities from Philadelphia chromosome-positive chronic myeloid leukemia. Br. J. Haematol. 1992; 82: 515–521
   PubMed Web of Science ®Google Scholar
• Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977; 270: 347–349
   PubMed Web of Science ®Google Scholar
• Lanotte M., Martin-Thouvenin V., Najman S., Balerini P., Valensi F., Berger R. NB-4, a maturation-inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080–1086
   PubMed Web of Science ®Google Scholar
• Kubonishi I., Machida K., Sonobe H., Ohtsuki Y., Akagi T., Miyoshi I. Two new human myeloid cell lines derived from acute promyelocytic leukemia and chronic myelogenous leukemia. Gann 1983; 74: 319–322
   PubMedGoogle Scholar
• Paul C. C., Tolbert M., Mahrer S., Singh A., Grace M. J., Baumann M. A. Cooperative effects of interleukin-3, interleukin-5 and granulocyte-macrophage colony stimulating factor: a new myeloid cell line inducible to eosinophils. Blood 1993; 81: 1193–1199
   PubMed Web of Science ®Google Scholar
• Saito H., Bourinbaiar A., Ginsburg M., Minato K., Ceresi E., Yamada K., Machover D., Breard J., Mathe G. Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 1985; 66: 1233–1240
   PubMed Web of Science ®Google Scholar
• Kishi K. A new leukemia cell line KU812 with Philadelphia chromosome characterized as basophil precursors. Leuk. Res. 1985; 9: 381–290
   PubMed Web of Science ®Google Scholar
• Butterfield J. H., Weiler D., Dewald G., Gliech G. J. Establishment of an immature mast cell line HMC-1 from a patient with mast cell leukemia. Leuk. Res. 1988; 12: 345–355
   PubMed Web of Science ®Google Scholar
• Lange B., Valtieri M., Santoli D., Caracciolo D., Rovera G. Growth factor requirements of childhood acute leukemia: Establishment of GM-CSF-dependent cell lines. Blood 1987; 70: 192–199
   PubMed Web of Science ®Google Scholar
• Chen P., Chiu C., Chiou T., Maeda S., Chiang H., Tzeng C., Sugiyama T., Chiang B. N. Establishment and characterization of a human monocytoid leukemia cell line, CTV-1. Gann 1984; 75: 660–664
   PubMedGoogle Scholar
• Nagata Y., Diamond B., Bloom B. R. The generation of human monocyte/macrophage cell lines. Nature 1983; 306: 597–599
   PubMed Web of Science ®Google Scholar
• Ohta M., Furukawa Y., Ide C., Akiyawa N., Utakoji T., Miura Y., Saito M. Establishment and characterization of four human monocytoid leukemia cell lines (JOSK-I, -S, -M and -K) with capacities of monocyte-macrophage lineage differentiation and constitutive production of interleukin-1. Cancer Res. 1986; 46: 3067–3074
   PubMed Web of Science ®Google Scholar
• Andersson S., Bergerheim U. S., Collins V. P., Childs C., Beran M., Sen S., Arden K., Pathak S., Siciliano M. J., Ost A. KBM-3, an in vitro model of human acute myelomonocytic leukemia. Exp. Hematol. 1992; 20: 361–367
   PubMed Web of Science ®Google Scholar
• Beran M., Pisa P., O'Brien S., Kurzrock R., Siciliano M., Cork A., Anderson B. S., Kohli V., Kantarjian H. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase. Cancer Res. 1993; 53: 3603–3610
   PubMed Web of Science ®Google Scholar
• Adachi N., Takaki K., Nakamura R., Ohta T., Naito M., Horiuchi S., Matsuda I. Establishment and character ization of a novel human monocytic leukemia cell line (KP-1) expressing scavenger receptor. Pediatr. Res. 1993; 34: 258–264
   PubMed Web of Science ®Google Scholar
• Treves A. J., Barak V., Biran S., Leizerowitz R., Polliack A. In vitro differentiation and establishment of cell lines derived from human monocytic leukemia cells. Immunol. Letters 1986; 12: 225–230
   PubMed Web of Science ®Google Scholar
• Treves A. J., Barak V., Biran S., Leizerowitz R., Polliack A. In vitro differentiation and establishment of cell lines derived from human myelomonocytic leukemia cells. Immunol. Lett 1986; 12: 225–230
   PubMed Web of Science ®Google Scholar
• Yanagisawa K., Horiuchi T., Fujita S. Establishment and characterization of a new human leukemia cell line ME-1 de rived from M4Eo. Blood 1991; 78: 451–457
   PubMed Web of Science ®Google Scholar
• Herrmann R., Han T., Barcos M. R., Lok M. S., Henderson E. S. Malignant lymphoma of pre-T-cell type terminating in acute myelocytic leukemia. A case report with enzymic and immunologic marker studies. Cancer 1980; 46: 1383–1388
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock H. W. L., Thiel E., Futterer A., Herzog V., Wirtz A., RiethmÜLler G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 1988; 15: 456–461
   Web of Science ®Google Scholar
• Stong R. C., Korsmeyer S. J., Parkin J. L., Arthur D. C., Kersey J. H. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B-lineage and monocytic characteristics. Blood 1985; 65: 21–31
   PubMed Web of Science ®Google Scholar
• Ogura M., Hamaguchi M. Coagulation and fibrinolysis system of a human monocytic leukemia cell line NOMO-I. J. Jpn. Reticulo System Soc. 1988; 28: 19–26
   Google Scholar
• Nara N., Suzuki T., Nagata K., Tohda S., Yamashita Y., Nakamura Y., Imai Y., Ario T., Minamihisamatsu M. Granulocyte colony stimulating factor-dependent growth of acute myeloblastic leukemia cell line. Jpn. J. Cancer Res. 1990; 81: 625–631
   PubMedGoogle Scholar
• Wang C., Curtis J. E., Geissler E. N., McCulloch E. A., Minden M. D. The expression of the proto-oncogene c-kit in the blast cells of AML. Leukemia 1989; 3: 699–702
   PubMed Web of Science ®Google Scholar
• Tohda S., Yang G. S., Ashman L. K., McCulloch E. A., Minden M. D. Relationship between c-kit expression and proliferation in acute myeloid leukemia cell lines. J. Cell. Physiol. 1993; 154: 410–418
   PubMed Web of Science ®Google Scholar
• Pirruccello S. J., Jackson J. D., Lang M. S., Deboer J., Mann S., Crouse D., Vaughan W. P., Dicke K. A., Sharp J. G. OMA-AML-1: a leukemie myeloid cell line with CD34+ progenitor and CD15+ spontaneously differentiating compartments. Blood 1987; 80: 192–199
   Google Scholar
• Tucker K. A., Lilly M. B., Heck L., Rado T. A. Characterization of a new human diploid myeloid leukemia cell line PLB-985 with granulocytic and monocytic differentiating capacity. Blood 1987; 70: 372–378
   PubMed Web of Science ®Google Scholar
• Bradley T. R., Pilkington G., Garson M., Hodgson G. S., Kraft N. Cell lines derived from a human myelomonocytic leukaemia. Br. J. Haematol. 1982; 51: 595–604
   PubMed Web of Science ®Google Scholar
• Lasky S. R., Bell W., Huhn R. D., Posnar M. R., Wiemann M., Calabresi P., Eil C. Effects of vitamin D3 on the human CML cell line: RWLeu 4. Cancer Res. 1985; 50: 3087–3094
   Google Scholar
• Kawaguchi R., Hosokawa Y., Komine A., Tsutsumi M., Hikiji K., Ishida-Okawara A., Suzuki K., Nakagawa T., Yamaguchi K. The monocytic cell line SKM-I strongly expresses the myeloperoxidase gene. Leukemia 1992; 6: 1296–1301
   PubMed Web of Science ®Google Scholar
• Tsuchiya S., Yamabe K., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 1980; 26: 171–176
   PubMed Web of Science ®Google Scholar
• Ohno H., Doi S., Fukuhara S., Yamasowa M., Kannagi M., Ishikura H., Nishikori M., Uchino H. Establishment of a new myeloid leukemia cell line TK-1 and isolation of cells having a translocation involving a band 17q23. Int. J. Cancer 1986; 37: 761–767
   PubMed Web of Science ®Google Scholar
• SundstrÖM C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line U-937. Int. J. Cancer 1976; 17: 565–577
   PubMed Web of Science ®Google Scholar
• Ohno H., Fukuhara S., Doi S., Yamasowa M., Arita Y., Sasada M., Ohno Y., Kasaka K., Uchino H. Establishment of a novel acute monoblastic leukemia cell line YK-M2 with a near-triploid karyotype. Cancer Res. 1986; 46: 6400–6405
   PubMed Web of Science ®Google Scholar
• Chiba S., Takaku F., Tange T., Shibuya K., Misawa C., Sasaki K., Miyagawa K., Yazaki Y., Hirai H. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: A parent line requiring granulocyte-macrophage colony stimulating factor or interleukia-3, and a subline requiring erythropoietin. Blood 1991; 78: 2261–2268
   PubMed Web of Science ®Google Scholar
• Martin P., Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233–1235
   PubMed Web of Science ®Google Scholar
• Okuno Y., Suzuki A., Ichiba S., Takahashi T., Nakamura K., Hitomi K., Saski R., Tada K., Imura H. Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells. Cancer 1990; 66: 1544–1551
   PubMed Web of Science ®Google Scholar
• Lozzio C. B., Lozzio B. B. Human chronic myeloid leukemia cell line with positive Philadelphia chromosome. Blood 1975; 45: 321–324
   PubMed Web of Science ®Google Scholar
• Furukawa T., Koike T., Ying W., Kishi K., Aoki S., Gotoh T., Hashimoto S., Saitoh H., Hanano M., Shinada S., Moriyama Y., Takahashi N., Endo Y., Okano H., Maekawa T., Abe T., Shibata A. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis. Leukemia 1994; 8: 171–180
   PubMed Web of Science ®Google Scholar
• Okano H., Okamura J., Yagawa K., Tasaka H., Motomura S. Human erythroid cell lines derived from a patient with acute erythrema. J. Cancer Res. Clin. Oncol. 1981; 102: 49–55
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Nakamoto B., Kurachi S., Tweeddale M., Messner H. Surface antigen profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood 1988; 72: 1029–1038
   PubMed Web of Science ®Google Scholar
• Hirata J., Sato H., Takahira H., Shiokawa S., Endo T., Nishimura J., Katsuno M. A novel CD10-positive erythroid cell line, RM10, established from a patient with CML. Leukemia 1990; 4: 365–372
   PubMed Web of Science ®Google Scholar
• Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y. F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line TF-1 that proliferates dependently on granulocyte-macrophage colony stimulating factor, interleukin-3 or erythropoietin. J. Cell Physiol. 1989; 140: 323–334
   PubMed Web of Science ®Google Scholar
• Endo K., Harigae H., Nagai T., Fujie H., Meguro K., Watanabe N., Furuyama K. Two chronic myeloid leukaemia cell lines which represent different stages of erythroid differentiation. Br. J. Haematol. 1993; 85: 653–662
   PubMed Web of Science ®Google Scholar
• Fugman D. A., Witte D. P., Jones C. L., Aronow B. J., Lieberman M. A. In vitro establishment and characterization of a human megakaryoblastic cell line. Blood 1990; 75: 1252–1261
   PubMed Web of Science ®Google Scholar
• Sato T., Fuse A., Eguchi M., Hayashi Y., Sugita K., Nakazawa S., Minato K., Shima Y., Komori I., Sunami S., Okimoto Y., Nakajima H. Establishment and characterisation of a megakaryoblastic cell line CMK from a Down's syndrome patient with acute megakaryoblastic leukaemia. Br. J. Haematol. 1989; 72: 184–190
   PubMed Web of Science ®Google Scholar
• Greenberg S. M., Rosenthal D. S., Greeley T. A., Tantravahi R., Handin R. I. Characterization of a new megakaryoblastic cell line: the DAMI cell. Blood 1988; 72: 1968–1977
   PubMed Web of Science ®Google Scholar
• Mouthon M. A., Freund M., Titeux M., Katz A., Guiehard J., Breton-Gorius J., Vainchenker W. Growth and differentiation of the human megakaryoblastic cell line ELF-153: a model for early stages of megakaryocytopoiesis. Blood 1994; 84: 1085–1097
   PubMed Web of Science ®Google Scholar
• Zipursky A., Vanek W., Grunberger T., Brown E. J., Wang H., Sutherland R., Yeo E., Cohen A., Freedman M. H. A megakaryoblastic cell line from a patient with Down syndrome-acute megakaryoblastic leukemia (DS-AMKL) in vitro differentiation of megakaryoblasts. Blood 1993; 82: 122a
   Web of Science ®Google Scholar
• Morgan D. Differential cytokine response of human lineage specific progenitor cell lines. Blood 1993; 82: 373a
   Web of Science ®Google Scholar
• Yasanuga M., Ryo R., Sawada Y., Konaka S., Taniguchi H., Sawada H., Goto M., Jikai J., Sugano W., Saigo K., Yamaguchi N. Extramedullary tumor as a presentation of leukemia: Establishment of a new human GPIIb- and GPIIIa-positive leukemia cell line. Ann. Hematol. 1994; 68: 145–151
   PubMed Web of Science ®Google Scholar
• Seigneurin D., Champelovier P., Mouchiroud G., Berthier R., Leroux D., Prenant M. Human CML cell line with Philadelphia chromosome exhibits megukaryocytic and erythroid characteristics. Exp. Hematol. 1987; 15: 822–832
   PubMed Web of Science ®Google Scholar
• Avanzi G. C., Lista P., Giovinazzo B., Miniero R., Saglio G., Benetton G., Coda R., Cattoretti G., Pegoraro L. Selective growth response to interleukin-3 of a human leukaemic cell line with megakaryoblastic features. Br. J. Haematol. 1988; 69: 359–366
   PubMed Web of Science ®Google Scholar
• Morgan D. A., Gumucio D. L., Brodsky I. Granulocyte-macrophage colony stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 1991; 78: 2860–2871
   PubMed Web of Science ®Google Scholar
• Ogura M., Morishima Y., Ohno R., Kato Y., Hirabayashi N., Nagura H., Saito H. Establishment of a novel human megakaryocytic leukemia cell line MEG-01 with Philadelphia chromosome. Blood 1985; 66: 1384–1392
   PubMed Web of Science ®Google Scholar
• Takeuchi S., Sugito S., Uemura Y., Miyagi T., Kubonishi I., Taguchi H., Enzan H., Obtsuki Y., Miyoshi I. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo. Leukemia 1992; 6: 588–594
   PubMed Web of Science ®Google Scholar
• Matsuo Y., Adachi T., Tsubota T., Imanshi J., Minowada J. Establishment and characterization of a novel megakaryoblastic cell line, MOLM-1, from a patient with CML. Human Cell 1991; 4: 261–264
   PubMedGoogle Scholar
• Tange T., Nakahara K., Mitani K., Yamasaki I., Yasuda H., Tanaka F., Mizuguchi M., Oda H., Yatomi Y., Takanashi R. Establishment of a human megakaryoblastic cell line (T-33) from chronic myeloid leukemia in megakaryoblastic crisis. Cancer Res. 1988; 48: 6137–6144
   PubMed Web of Science ®Google Scholar
• Komatsu N., Nakauchi H., Miwa A., Ishihara T., Eguchi M., Moroi M., Okada M., Sato Y., Wada H., Yawata Y. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocytemacrophage colony stimulating factor, interleukin-3 or erythropoietin for growth and survival. Cancer Res. 1991; 51: 341–348
   PubMed Web of Science ®Google Scholar
• Hassan H. T. Synergism between differentiation inducing agents: preclinical and clinical studies. The Pharmacology of Cell Differentiation, R. A. Rifkind. Elsevier, Amsterdam 1993; 277–294
   Google Scholar
• Kindler V., Shields J., Ayer D., Mazzei G. J. Growth regulation of the AML-193 leukemic cell line: evidence for autocrine production of granulocyte-macrophage colony stimulating factor and inhibition of granulocyte colony stimulating factor-dependent cell proliferation by IL-1 and TNF. Int. J. Cancer 1991; 47, 450–454
   PubMed Web of Science ®Google Scholar
• Gaffney E. V., Stoner C. R., Lingenfelter S. E., Wagner L. A. Demonstration of IL-alpha and beta secretion by the monocytic leukemia cell line: THP-1. J. Immunol. Methods 1989; 122: 211–218
   PubMed Web of Science ®Google Scholar
• Kitamura T., Takaku F., Miyajima A. Interleukin-1 upregulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line TF-1. Int. Immunol. 1991; 3: 571–577
   PubMed Web of Science ®Google Scholar
• Arock M., Merle-Beral M., Dugas B. Interleukin-4 release by human leukemic and activated normal basophils. J. Immunol. 1993; 151: 1441–1447
   PubMed Web of Science ®Google Scholar
• Ingley E., Young I. G. Characterization of a receptor for interleukin-5 on human eosinophils and the myeloid leukemia cell line HL-60. Blood 1991; 78: 339–344
   PubMed Web of Science ®Google Scholar
• Noma T., Nakakubo H., Hama K., Honjo T. Multiple effects of human recombinant interleukin-4 on human myeloid monocyte cell line. Immunol. Letters 1989; 21: 323–328
   PubMed Web of Science ®Google Scholar
• Weidmann E., Brieger J., Fenchel K., Mitrou P. S., Bergmann L., Hoelzer D. Expression of the interleukin-2 receptor-alpha, β and gamma chains on AML blasts and on AML-derived cell lines. Proc. AACR 1994; 35: 531
   Google Scholar
• Ziegler-Heitbrock H. W. L., Schraut W., Wendelgass P. Distinct patterns of differentiation induced in the monocytic cell line Mono Mac 6. J. Leuk. Biol. 1994; 55: 73–80
   PubMed Web of Science ®Google Scholar
• Selvan R. S., Butterfield J. H., Krangel M. S. Expression of multiple chemokine genes by a human mast cell leukemia HMC-1. J. Biol. Chem. 1994; 269: 13893–13898
   PubMed Web of Science ®Google Scholar
• Suzuki K., Yamakawa Y., Matsuo Y., Kamiya T., Minowada J., Mizuno S. Isolation and amino acid sequence of a chemotactic protein, interleukin-8, from a human myeloid leukemia cell line ML-1. Immunol. Letters 1993; 36: 71–81
   PubMed Web of Science ®Google Scholar
• Kobayashi S., Teramura M., Sugawara I., Oshimi K., Mizoguchi H. Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood 1993; 81: 889–893
   PubMed Web of Science ®Google Scholar
• Imai Y., Nara N., Tohda S. Antiproliferative and differentiative effects of recombinant interleukin-4 on a granulocyte colony stimulating factor-dependent myeloblastic leukemic cell line. Blood 1991; 78: 471–478
   PubMed Web of Science ®Google Scholar
• Brennan J. K., Lee K. S., Abboud C. N., Erickson-Miller C. L., Keng P. C. Interactions of dimethylsulphoxide and granulocyte-macrophage colony stimulating factor in the growth and maturation of HL-60 cells. J. Cell Physiol. 1987; 132: 246–254
   PubMed Web of Science ®Google Scholar
• Irvine A. E., Berney J. J., Francis G. E. Dissociation of the proliferation and differentiation stimuli of granulocyte colony stimulating factor. Leukemia 1990; 4: 203–209
   PubMed Web of Science ®Google Scholar
• Hassan H. T., Tsiriyotis C., Maurer H. R., Spandidos D. Human interleukin-3 opposes the effects of vitamins A and D on HL-60 human myeloid leukemia cells. Anticancer Res. 1992; 12: 821–825
   PubMed Web of Science ®Google Scholar
• Hassan H. T. In vitro differentiation induction of human normal and leukemia myeloid progenitor cells. Doctorate (Ph.D.) Dissertation. University of Cambridge Clinical School, England, UK 1990
   Google Scholar
• Chen Y. Z., Gu X. F., Caen J. P., Han Z. C. Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells. Br. J. Haematol. 1994; 88: 481–487
   PubMed Web of Science ®Google Scholar
• Oval J., Taetle R. Factor-dependent human leukemia cell lines: new models for regulation of acute non-lymphocytic leukemia cell growth and differentiation. Blood Rev. 1990; 4: 270–279
   PubMed Web of Science ®Google Scholar
• Hassan H. T. In vitro interaction between retinoids and cytokines in human myeloid leukemia cells. Eur. J. Cancer 1991; 27: 1182–1183
   PubMed Web of Science ®Google Scholar
• Hassan H. T. Recombinant human interleukin-6 enhances the antiproliferation and differentiation inducing effects of retinoic acid in HL-60 human myeloid leukemia cells. Clin. Exp. Pharmacol. Physiol. 1992; 18: 847–851
   Web of Science ®Google Scholar
• Nilsson G., Carlsson M., Jones I., Ahlstedt S., Matsson P., Nilsson K. TNF-alpha and interleukin-6 induce differentiation in the human basophilic leukemia cell line KU812. Immunol. 1994; 81: 73–78
   PubMed Web of Science ®Google Scholar
• Duits A. J., Dimjati W., Van Der Winkel J. G., Capel P. J. Synergism of interleukin-6 and vitamin D3 in induction of myeloid differentiation of human leukemic cell line. J. Leuk. Biol. 1992; 51: 237–243
   PubMed Web of Science ®Google Scholar
• Suzuki T., Morio T., Tahda S. Effects of interleukin-6 and granulocyte colony stimulating factor on the proliferation of leukemic blast progenitors from AML patients. Jpn. J. Cancer Res. 1989; 81: 979–986
   Google Scholar
• Maekawa T., Metcalf D., Gearing D. P. Enhanced suppression of human myeloid leukemic cell lines by combinations of interleukin-6, leukemia inhibitory factor, granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor. Int. J. Cancer 1990; 45: 353–358
   PubMed Web of Science ®Google Scholar
• Young D. C., Wagner K., Griffin J. D. Constitutive expression of the granulocyte-macrophage colony stimulating factor gene in acute myeloblastic leukemia. J. Clin. Invest. 1987; 79: 200–206
   Web of Science ®Google Scholar
• Griffin J. D., Rambaldi A., Vellenga E., Young D. C., Ostapovicz A., Cannistra S. A. Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secret colony stimulating factors. Blood 1987; 70: 1218–1221
   PubMed Web of Science ®Google Scholar
• Cheng G. Y., Kellecher C. A., Miyauchi J., Wang C., Wong G., Clark S. C., McCulloch E. A., Minden M. D. Structure and expression of genes of granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor in blast cells from patients with acute myeloblastic leukemia. Blood 1988; 71: 35–41
   Google Scholar
• Kaufman D., Baer M., Gao X. Z., Wang Z., Preisler H. D. Enhanced expression of granulocyte-macrophage colony stimulating factor gene in acute myeloblastic leukemia cells following in vitro blast cell enrichment. Blood 1988; 72: 1329–1332
   PubMed Web of Science ®Google Scholar
• Young D. C., Demetri G. D., Ernst T. J., Cannistra S., Griffin J. D. In vitro expression of colony stimulating factor genes by human acute myeloblastic leukemia cells. Exp. Hematol 1988; 16: 378–382
   PubMed Web of Science ®Google Scholar
• Oster W., Cicco N. A., Klein H., Hirano T., Kishimoto T. Participation of cytokine interleukin-6, tumour necrosis factor-alpha and interleukin-1 Beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest. 1989; 84: 451–457
   PubMed Web of Science ®Google Scholar
• Van Der School C. E., Jansen P., Poorter M., Wester M. R., Von Dem Borne A. E., Aarden L. A., Van Oers R. H. Interleukin-1 and interleukin-6 production in acute leukemia with monocytoid differentiation. Blood 1989; 74: 2081–2087
   PubMed Web of Science ®Google Scholar
• Migliaccio G., Migliaccio A. R., Ruscetti S., Adamson J. W. The growth of erythroleukemia cells is mediated by autocrine production of a factor with biological activity similar to IL-3. Blood 1989; 73: 1770–1777
   PubMed Web of Science ®Google Scholar
• Mitjavila M. T., Le Codevic J. P., Navarro S., Villeval J. L. Autocrine stimulation by erythropoietín and autonomous growth of human erythroleukemia cells in vitro. J. Clin. Invest. 1991; 88: 789–797
   PubMed Web of Science ®Google Scholar
• Brach M. A., LÖWenberg B., Montovani L., Schwulea U., Mertelsmann R., Herrmann F. Interleukin-6 as an intermediate in interleukin-1-induced proliferation of leukemic human megakaryoblasts. Blood 1990; 76: 1972–1979
   PubMed Web of Science ®Google Scholar
• Rigo A., Vinate F., Ricetti M., Tecchio C., Cassatella M. A., Pizzolo G. Differentiation related production of interleukin-8 by acute myeloid leukaemia blasts. Br. J. Haematol. 1994; 84, Suppl. 1, 72a
   Google Scholar
• Baumann M. A., Paul C. C., Grace M. J. Effects of interleukin-5 on AML. Am. J. Hematol. 1992; 39: 269–274
   PubMed Web of Science ®Google Scholar
• Ema H., Kitano K., Suda T., Sato Y., Muroi K., Ohta M., Yoshida M. In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of AML with the translocation t(8;21)(q22;q22). Blood 1990; 75: 350–356
   PubMed Web of Science ®Google Scholar
• Touw I., Donath J., Pouwels K., Van Buitenen C., Schipper P., Santini V., Hagemeijer A., LÖWenberg B., Delwel R. Acute myeloid leukemia with chromosomal abnormalities involving the 21 q22 region identified by their in vitro responsiveness to interleukin-5. Leukemia 1991; 5: 687–692
   PubMed Web of Science ®Google Scholar
• Rees J. K. H., Drach J., Estrov Z., Shao S., Collins D., Andreeff M. The expression of cytokine receptors on acute myeloid leukemia. Blood 1992; 80: 36a
   Google Scholar
• Dreyfus F., Picard F., Gisselbrecht S., Varet B., Tambourin P. E., Fichelson S. ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines. Nouv. Rev. Fr. Hematol. 1989; 31: 217–221
   PubMedGoogle Scholar
• Collins S. J., Groudine M. Rearrangement and amplification of c-abl sequences in the human CML cell line K562. Proc. Natl. Acad. Sci. USA 1983; 80: 4813–4817
   PubMed Web of Science ®Google Scholar
• Blick M., Andersson B. S., Gutterman J. U., Keating A., Beran M. The c-abl, ber and C genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myeloid leukemia. Leuk. Res. 1986; 10: 1401–1409
   PubMed Web of Science ®Google Scholar
• Bartella C., Pelicci P. G., Kenyon L. C., Smith S. D., Dalla Favera R. Relationship between the c-myb locus and the 6q- chromosomal aberration in leukemias and lymphomas. Science 1987; 225: 1064–1067
   Google Scholar
• Collins S. J. HL-60 promyelocytic leukemia cell line: proliferation, differentiation and cellular oncogene expression. Blood 1987; 70: 1233–1244
   PubMed Web of Science ®Google Scholar
• Bi S., Hughes T., Bungey J., Chase A., De Fabritiis P., Goldman J. M. p53 in chronic myeloid leukemia cell lines. Leukemia 1992; 6: 839–842
   PubMed Web of Science ®Google Scholar
• Hu Z. B., Ma W., Uphoff C. C., Quentmeier H., Drexler H. G. c-kit expression in human megakaryoblastic leukemia cell lines. Blood 1994; 83: 2133–2144
   PubMed Web of Science ®Google Scholar
• Holt J. T., Redner R. L., Nienhuis A. W. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol. Cell Biol 1988; 8: 963–973
   PubMed Web of Science ®Google Scholar
• Anfossi G., Gewirtz A. M., Calabretta B. An oligomer complementary to c. myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc. Natl. Acad. Sci. USA 1989; 86: 3379–3383
   PubMed Web of Science ®Google Scholar
• Caracciolo D., Valtieri M., Venturelli D., Peschle C., Gewirtz A. M., Calabretta B. Lineage-specific requirement of c-abl function in normal hematopoiesis. Science 1989; 245: 1107–1110
   PubMed Web of Science ®Google Scholar
• Layton D. M., Mufti G. J., Lyons J., Janssen J. W. G., Bartram C. R. Loss of ras oncogene mutation in a myelodysplastic syndrome after low dose cytarabine therapy. New Engl. J. Med. 1988; 318: 1468–1469
   PubMed Web of Science ®Google Scholar
• Shen D. W., Real F. X., De Leo A. B., Old L. J., Marks A., Rifkind R. A. Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division. Proc. Natl. Acad. Sci. USA 1983; 80: 5919–5922
   PubMed Web of Science ®Google Scholar
• Muller R., Curran T., Muller D., Guilbert L. Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature 1985; 314: 546–548
   PubMed Web of Science ®Google Scholar
• Ferrari S., Donelli A., Manfredini R., Sarti M., Roncalgi R., Tagliafico E., Rossi E., Torelli G., Torelli U. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL-60 cells. Cell Growth Differ 1990; 1: 543–548
   PubMedGoogle Scholar
• Wu Zhu J. Q., Han K. K, Zhu D. X. The role of c-fms oncogene in the regulation of HL-60 cell differentiation. Oncogene 1990; 5: 873–877
   PubMed Web of Science ®Google Scholar
• Sherman M. L., Stone R. M., Datta R., Bernstein S. H., Kufe D. W. Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemia cells. J. Biol. Chem. 1990; 265: 3320–3323
   PubMed Web of Science ®Google Scholar
• Quintrell N., Lebo R., Varmus H., Bishop J. M., Pettenati M. J., Le Beau M. M., Diaz M. O., Rowley J. D. Identification of a human gene HCK that encodes a protein tyrosine kinase and is expressed in hemopoietic cells. Mol. Cell Biol. 1987; 67: 2275–2278
   Google Scholar
• Sartor Q., Gregory F. S., Templeton N. S., Pawar S., Perlmutter R. M., Rosen N. Selective expression of alternative Iek mRNA inhuman malignant cell lines. Mol. Cell Biol. 1989; 9: 2983–2988
   PubMed Web of Science ®Google Scholar
• Maru Y., Hirai H., Takaku F. Human Itk: gene structure and preferential expression in human leukemic cells. Oncogene Res. 1990; 5: 199–204
   PubMedGoogle Scholar
• Hashimoto K., Kishimoto A., Aihara H., Yasuda I., Mikawa K., Nishikuza Y. Protein kinase C during differentiation of human promyelocytic leukemia cell line HL-60. FEBS Lett. 1990; 263: 31–34
   PubMed Web of Science ®Google Scholar
• Barnekow A., Gessler M. Activation of pp60c-src kinase during differentiation of myelomonocytic cells in vitro. EMBO J. 1986; 5: 701–705
   PubMed Web of Science ®Google Scholar
• Ernst T. J., Ritchie A. R., O'Rourke R., Griffin J. D. Colony stimulating factor gene expression in human acute myelogenous leukemia cells is posttranscriptionally regulated. Leukemia 1989; 3: 620–625
   PubMed Web of Science ®Google Scholar
• Demetri G. D., Ernst T. J., Pratt E. S., II, Zenzie B. W., Rheinwald J. G., Griffin J. D. Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes. J Clin. Invest. 1990; 86: 1261–1269
   PubMed Web of Science ®Google Scholar
• Bortner D. M., Ulivi M. F., Roussel M. F., Ostrowski M. C. The carboxy-terminal catalytic domain of the GTPase-activating protein inhibits nuclear signal transduction and morphological transformation mediated by the CSF-1 receptor. Genes Dev. 1991; 4: 1777–1785
   Web of Science ®Google Scholar
• Satoh T., Nakafuku M., Miyajima A., Kaziro Y. Involvement of ras p21 protein in signal transduction pathways from interleukin-2, interleukin-3, and granulocyte-macrophage colony stimulating factor but not from interleukin-4. Proc. Natl. Acad. Sci. USA 1991; 88: 3314–3318
   PubMed Web of Science ®Google Scholar
• Nakafuku M., Satoh T., Kaziro Y. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6 induce an accumulation of an active ras-GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem. 1992; 267: 19448–19454
   PubMed Web of Science ®Google Scholar
• Izquierdo M., Downward J., Otani H., Leonard W. J., Cantrell D. A. Interleukin-2-activation of p21 ras in murine myeloid cells transfected with human IL-2 receptor Beta chain. Eur. J. Immunol. 1992; 22: 817–821
   PubMed Web of Science ®Google Scholar
• Torti M., Marti K. B., Altschuler D., Yamamoto K., Lapetina E. G. Erythropoietin induces p21 ras activation and p120GAP tyrosine kinase phosphorylation in human erythroleukemia cells. J. Biol. Chem. 1992; 267: 8293–8298
   PubMed Web of Science ®Google Scholar
• Carrol M. P., Spivak J. L., McMahon M., Weich N., Rapp U. R., May W. S. Erythropoietin induces Raf-1 activation and Raf-1 is required for Epo-mediated proliferation. J. Biol. Chem. 1991; 266: 14964–14969
   PubMed Web of Science ®Google Scholar
• Cooper R. S., Blackmon D., Pearson L. L., Rivero J. I., Spillers R. E., Adunyah S. E. Erythropoietin and interleukin-8 induce tyrosine phosphorylation and activation of kinase activities of c-fes, c-raf and ERK1. Proc. AACR 1994; 35: 456a
   Google Scholar
• Osborn L., Kunkel S., Nabel G. J. Tumour necrosis factor-alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor KB. Proc. Natl. Acad. Sci. USA 1989; 86: 2336–2340
   PubMed Web of Science ®Google Scholar
• Adachi K., Saito H. Induction of janB expression but not c-jun by granulocyte-macrophage colony stimulating factor or macrophage colony stimulating factor in the proliferative response of human myeloid leukemia cells. J. Clin. Invest. 1992; 89: 1657–1661
   PubMed Web of Science ®Google Scholar
• Song Y. H., Lin Y. M., Kong X. Y., Li M., Zheng G. G. Up-regulation of expression of oncogenes on J6-1 leukemic cells by recombined growth factor. Exp. Hematol. 1992; 20: 328a
   PubMed Web of Science ®Google Scholar
• Brach M. A., Klein H., Platzer E., Mertelsmann R., Hermann F. Effect of interleukin-3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts. Exp. Hematol. 1990; 18: 748–753
   PubMed Web of Science ®Google Scholar
• Hatakeyama M., Kono T., Kobayashi N., Kawahara A., Levin S. D., Perlmutter R. M., Tanguichi T. Interaction of IL-2 receptor with the sre-family kinase p561ck. Science 1991; 252: 1523–1528
   PubMed Web of Science ®Google Scholar
• Von Boros I., Korenyi A. über einen Fall von akuter megakaryoblasten Leukämie: Zugleich einige Bemerkungen zum Problem der akuter Leukämie. Z. Kin. Med. 1931; 118: 697–700
   Google Scholar
• Caimey A. E. L., McKenna R., Arthur D. C., Nesbit M. E., Woods W. G. Acute megakaryoblastic leukaemia in children. Br. J. Haematol. 1986; 63: 541–546
   PubMed Web of Science ®Google Scholar
• San Miguel J. F., Gonzalez M., Canizo M. C. Leukemias with megakaryoblastic involvement: clinical, hematologic and immunologic characteristics. Blood 1988; 72: 402–407
   PubMed Web of Science ®Google Scholar
• Koike T., Urushujama M., Narita M., Saitoh H., Ishida F., Imashuku S., Morioka Y., Utsumi J. Target cell of leukemic transformation in acute megakaryoblastic leukemia. Am. J. Hematol. 1990; 34: 252–258
   PubMed Web of Science ®Google Scholar
• Cuneo A., Mecucci C., Kerim S., Van Den Berghe E., Dal Cir P., Van Orshoven A., Rodhain J., Bosly A., Michaux J. L., Martiat P. Multiponent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients. Blood 1989; 74: 1781–1790
   PubMed Web of Science ®Google Scholar
• Eguci M., Ozawa T., Sakakibara M. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients. Cancer 1992; 70: 451–458
   PubMed Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Caen J. P. Megakaryocytopoiesis: characterization and regulation in normal and pathologic states. Int. J. Haematol. 1991; 54: 3–14
   PubMed Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Tenza D., Caen J. P. Negative regulation of human megakaryocytopoiesis by human platelet 4 and beta-thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and ITP. Br. J. Haematol. 1990; 74: 395–401
   PubMed Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Wan H. Y., Caen J. P. New insights into the regulation of megakaryocytopoiesis by haemopoietic and fibroblastic growth factors and TGF-β1. Br. J. Haematol. 1992; 81: 1–5
   PubMed Web of Science ®Google Scholar
• Hoffman R., Briddell R. A., Straneva J. E., Brandt J. E., Bruno E., Ganser A., Hudson N., Guscar T. Cytokine control of human megakaryocytopoiesis. Prog. Clin. Biol. Res. 1990; 338: 75–103
   PubMedGoogle Scholar
• Navarro S., Mitjavila M. T., Katz A., Vainchenker W. Expression of interleukin-6 and its specific receptor by untreated and TPA-stimulated human erythroid and megakaryocytic cell lines. Exp. Hematol. 1991; 19: 11–17
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T. H., Raines E., Collins S., Nakamoto B., Tweeddale M., Ross R. Constitutive and inducible secretion of platelet-derived growth factor analogues by human leukemic cell lines coexpressing erythroid and megakaryocytic markers. J. Clin. Invest. 1989; 79: 859–866
   Web of Science ®Google Scholar
• Hassan H. T., Hanauske A.-R., Lux E., Kleine H.-D., Herbst H., Freund M. A new fibroblast growth stimulating activity from the human megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo findings. Hematol. Oncol., 13, in press
   Google Scholar
• Ishibashi T., Kimura H., Uchida T., Ariyone S., Friese P., Burnstein S. A. Human interleukin-6 is a direct promoter of maturation of megakaryocyte in vitro. Proc. Natl. Acad. Sci. USA 1989; 86: 5953–5960
   PubMed Web of Science ®Google Scholar
• Zeidler C., Kanz L., Hurkuck F., Souza L., Welte K. In vivo effects of interleukin-6 and leukaemia inhibitory factor on thrombopoiesis in primates. Cytokines in Hemopoiesis, Oncology and AIDS II, M Freund, H Link, RE Schmidt, K Welte. Springer Verlag. 1992; 411–416
   Google Scholar
• Fuse A., Kakuda H., Shima Y. Interleukin-6, a possible autocrine growth and differentiation factor for the human megakaryoblastic cell line, CMK. Br. J. Haematol. 1992; 77, 32–36
   Web of Science ®Google Scholar
• Brach M. A., LÖWenberg B., Mantovani L., Schwulera U., Mertelsmann R., Herrmann F. Interleukin-6 is an intermediate in interleukin-1-induced proliferation of leukemie human megakaryoblasts. Blood 1992; 76: 1972–1979
   Web of Science ®Google Scholar
• Miyauchi J., Sugita K., Okui M., Taguchi N., Clark S. C., Shimizu K. Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultrastructural cytochemical study. J. Cell Physiol. 1991; 148: 404–413
   PubMed Web of Science ®Google Scholar
• Hassan H. T., Grell S., Borrmann-Danso U., Freund M. Effect of recombinant human interferons in inducing differentiation of acute megakaryoblastic leukaemia blast cells. Leuk. Lymphoma, 15, in press
   Google Scholar
• Sonoda Y., Kuzuyama Y., Tanaka S., Yokota S., Maekawa T., Clark S. C., Abe T. Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood 1993; 81: 624–630
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddle M. M., Oort P. J., Hagen E. S. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand: thrombopoietin. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar